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Background. Extramedullary hematopoiesis is most often seen in reticuloendothelial organs specially spleen, liver, or lymph
nodes, and it is rarely seen in lung parenchyma. Almost all reported cases of pulmonary extramedullary hematopoiesis occurred
following myeloproliferative disorders specially myeloﬁbrosis. Other less common underlying causes are thalassemia syndromes
andotherhemoglobinopathies.Therewasnotanyreportedcaseofpulmonaryextramedullaryhematopoiesisinasthmaticpatients
in the medical literature. Case. Here we reported a 65-year-old lady who was a known case of bronchial asthma with recent
developed right lower lobe lung mass. Chest X-ray and CT studies showed an inﬁltrating mass resembling malignancy. Fine needle
aspiration cytology of mass revealed pulmonary extramedullary hematopoiesis. The patient followed for 10 months with serial
physical examination and laboratory evaluations which were unremarkable. Conclusion. Extramedullary hematopoiesis of lung
parenchyma can be mistaken for lung cancer radiologically. Although previous reported cases occurred with myeloﬁbrosis or
hemoglobinopathies, we are reporting the ﬁrst case of asthma-associated extramedullary hematopoiesis.
1.Introduction
Pulmonary extramedullary hematopoiesis is a rare condition
and most commonly occurs in patient, with chronic myelo-
proliferative disorders specially myeloﬁbrosis with myeloid
metaplasia [1]. Other underlying causes include hemoglo-
binopathies such as thalassemia syndromes, sickle cell ane-
mia, and other chronic hemolytic anemias. We reported an
unusual case of pulmonary extramedullary hematopoiesis in
an old lady with chronic asthma. The presumptive patho-
genetic mechanism for the development of this condition in
asthmaisthepresenceofchronicallergenexposuretoinduce
hematopoieticstemcellstothesiteofinﬂammationresulting
in extramedullary hematopoiesis.
2.CaseReport
A 65-year-old lady was referred to Namazi hospital aﬃliated
to Shiraz University of Medical Sciences because of worsen-
ing of her chronic airway disease. She had been conﬁrmed
as a typical case of asthma for about 40 years. She was non-
smoker with no history of fever, weight loss, or chest pain.
Her past medical history was not signiﬁcant except for a
chronic asthma which was controlled with inhalation of
bronchodilator sprays, sodium cromolyn (Intal), and PRN
corticosteroids. On physical examination, the general condi-
tionwaswell,withnosignofrespiratorydistress.Thepatient
was not febrile. There was no lymphadenopathy or hepa-
tosplenomegaly. Chest examination revealed mild wheezing
in both lung regions and decreased breathing sounds spe-
cially at the right lung base. Laboratory tests showed Hb:
12.8, Hct: 39%, and Leukocyte count: 8900/µL with mild eo-
sinophilia and platelet count: 420000/µL. Serum chemistry
proﬁle including liver function tests, FBS, renal function
tests, alkaline phosphatase, and calcium was unremarkable.
Chest X-ray showed mild hyperinﬂation and diﬀuse opacity
at the right lower lobe (Figure 1). A contrast-enhanced
CT of chest showed an inﬁltrating mass at the right
lower lobe (Figure 2). With the presumptive diagnosis of2 Case Reports in Medicine
Figure 1: Chest X-ray: inﬁltration in the base of both lungs.
Figure 2:AxialCTscanofthechest,lungwindow:denseconsolida-
tion in the posterior aspect of the right lung. A few other smaller in-
ﬁltrations are also seen in the left lung in this region. FNA is taken
from right side.
malignancy ﬁne needle aspiration under guide of CT was
performed; the smears were subsequently stained using
Wright and modiﬁed Papanicolaou methods, respectively.
The microscopic examination revealed hypercellular smears
composed of islands of erythroid precursors, myeloid series,
and some mature and immature megakaryocytes (Figures 3,
4 and 5). Considering the deﬁnite diagnosis of pulmonary
extramedullary hematopoiesis, bone marrow aspiration and
biopsy were performed and showed normocellular marrow
without evidence of myeloﬁbrosis in special stains. The
patient was followed during a laboratory investigation plan
for 10 months with routine treatments for her asthma, but
there was not any change toward malignancy or myeloﬁbro-
sis and any other complications.
3. Discussion
Although extramedullary hematopoiesis is a common ﬁnd-
ing in liver, spleen, or lymph nodes, it is a rare condition
reported in the lung parenchyma. Most of the reported pul-
monary extramedullary hematopoiesis is seen in myeloﬁbro-
sis with myeloid metaplasia, a subgroup of chronic myelo-
Figure 3: Low-power view of FNA cytology of lung mass shows he-
matopoetic cells admixed with few fat cells. Wright stain ×100.
Figure 4: Myeloid and erythroid cells in mid-power microscopic
view. Wright stain ×400.
Figure5:Amegakaryocyteinﬁnalstageofmaturation.Wrightstain
×400.
proliferative disorders. Rumi et al. presented a case of pul-
monary extramedullary hematopoiesis as initial symptom of
myeloﬁbrosis. They concluded that early recognition of pul-
monary extramedullary hematopoiesis may prevent pulm-
onary hypertension of myeloﬁbrosis because of early cytore-
duction therapy [1]. Kumar et al. also reported a case of pul-
monary extramedullary hematopoiesis presented with lungCase Reports in Medicine 3
mass which was diagnosed by ﬁne needle aspiration cyto-
logy[2].InanotherstudyHsuetal.explainedacaseofextra-
medullary hematopoiesis mimicking metastatic lung carci-
noma. The patient presented with a left lower lobe lung car-
cinoma and left pleural masses, initially thought inoperable
metastatic disease radiographically but ﬁne needle aspiration
ofpleuralmassesrevealedextramedullaryhematopoiesis[3].
Panditetal.andSehmietal.inanotherstudyshowedthesig-
niﬁcance for mobilization of hematopoietic progenitor cells
in allergic inﬂammation localized in the lung parenchyma of
asthmatic patients. The progenitor cells are mobilized from
bone marrow and migrate to lung parenchyma [4, 5]. In the
current study we reported a case of chronic asthma who was
presented with progressive dyspnea and an inﬁltrating right
lower lobe mass diagnosed as extramedullary hematopoiesis
by ﬁne needle aspiration cytology. Bone marrow aspiration
and biopsy were unremarkable, and 10-month followup of
the patient was unchanged. It ﬁnally concluded that the
possible cause of extramedullary hematopoiesis was most
likely due to chronic hypoxia and localized allergic inﬂam-
matory cells inﬁltration and their cytokine secretions which
can recruit progenitor cells to that area, causing proliferation
of marrow elements. Although asthma is a common disease,
such phenomenon is not seen before. We think there are few
considerations regarding this rare condition which include
chronicity of asthma in this patient and poor disease control
possibly due to low socioeconomic condition and being far
from good health care. Furthermore, such lesions are more
likely seen under microscopic examination, and the tissue
biopsy is usually not performed in asthma patients.
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